- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/04 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 231/04
Total number of patents in this class: 55
10-year publication summary
|
1
|
3
|
3
|
7
|
2
|
4
|
5
|
4
|
4
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20933 |
5 |
| The General Hospital Corporation | 4733 |
4 |
| The Broad Institute, Inc. | 1808 |
4 |
| Massachusetts Institute of Technology | 10057 |
3 |
| The Feinstein Institute for Medical Research | 254 |
3 |
| FMC Corporation | 844 |
3 |
| FUJIFILM Corporation | 29367 |
2 |
| Children's Medical Center Corporation | 1868 |
2 |
| Council of Scientific & Industrial Research | 1425 |
2 |
| National Institute of Biological Sciences, Beijing | 98 |
2 |
| Neuropro Therapeutics, Inc. | 20 |
2 |
| Tokyo Ohka Kogyo Co., Ltd. | 1542 |
2 |
| Psy Therapeutics, Inc. | 14 |
2 |
| Janssen Pharmaceutica N.V. | 3392 |
1 |
| Centre National de La Recherche Scientifique | 10418 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6408 |
1 |
| The Regents of the University of Michigan | 4698 |
1 |
| The Trustees of the University of Pennsylvania | 4322 |
1 |
| Argusina, Inc. | 2 |
1 |
| Assistance Publique - Hopitaux de Paris | 1000 |
1 |
| Other owners | 12 |